Literature DB >> 3879206

Rainfall and epizootic Rift Valley fever.

F G Davies, K J Linthicum, A D James.   

Abstract

Epizootic Rift Valley fever (RVF) has occurred in Kenya four times over the last 30 years. Widespread, frequent, and persistent rainfall has been a feature of these epizootic periods. A composite statistic, based upon measurements of these rainfall characteristics, is positive during periods of epizootic Rift Valley fever. The heavy rainfall raises the level of the water table in certain areas, flooding the grassland depressions (dambos) that are the habitat of the immature forms of certain ground-pool-breeding mosquitos of the genus Aedes. RVF virus is probably transmitted transovarially in these species, very large numbers of which emerge under these damp conditions. This is when clinical signs of the disease are first seen.

Entities:  

Mesh:

Year:  1985        PMID: 3879206      PMCID: PMC2536443     

Source DB:  PubMed          Journal:  Bull World Health Organ        ISSN: 0042-9686            Impact factor:   9.408


  79 in total

1.  Epidemiologic and clinical aspects of a Rift Valley fever outbreak in humans in Tanzania, 2007.

Authors:  Mohamed Mohamed; Fausta Mosha; Janeth Mghamba; Sherif R Zaki; Wun-Ju Shieh; Janusz Paweska; Sylvia Omulo; Solomon Gikundi; Peter Mmbuji; Peter Bloland; Nordin Zeidner; Raphael Kalinga; Robert F Breiman; M Kariuki Njenga
Journal:  Am J Trop Med Hyg       Date:  2010-08       Impact factor: 2.345

Review 2.  Emerging infectious diseases: the Bunyaviridae.

Authors:  Samantha S Soldan; Francisco González-Scarano
Journal:  J Neurovirol       Date:  2005-10       Impact factor: 2.643

3.  Prediction of a Rift Valley fever outbreak.

Authors:  Assaf Anyamba; Jean-Paul Chretien; Jennifer Small; Compton J Tucker; Pierre B Formenty; Jason H Richardson; Seth C Britch; David C Schnabel; Ralph L Erickson; Kenneth J Linthicum
Journal:  Proc Natl Acad Sci U S A       Date:  2009-01-14       Impact factor: 11.205

4.  Genetic evidence for Rift Valley fever outbreaks in Madagascar resulting from virus introductions from the East African mainland rather than enzootic maintenance.

Authors:  Serena A Carroll; Jean-Marc Reynes; Marina L Khristova; Soa Fy Andriamandimby; Pierre E Rollin; Stuart T Nichol
Journal:  J Virol       Date:  2011-04-20       Impact factor: 5.103

5.  A statistical model of Rift Valley fever activity in Egypt.

Authors:  John M Drake; Ali N Hassan; John C Beier
Journal:  J Vector Ecol       Date:  2013-12       Impact factor: 1.671

6.  Patterns of Rift Valley fever activity in Zambia.

Authors:  F G Davies; E Kilelu; K J Linthicum; R G Pegram
Journal:  Epidemiol Infect       Date:  1992-02       Impact factor: 2.451

7.  An outbreak of Rift Valley fever in Northeastern Kenya, 1997-98.

Authors:  Christopher W Woods; Adam M Karpati; Thomas Grein; Noel McCarthy; Peter Gaturuku; Eric Muchiri; Lee Dunster; Alden Henderson; Ali S Khan; Robert Swanepoel; Isabelle Bonmarin; Louise Martin; Philip Mann; Bonnie L Smoak; Michael Ryan; Thomas G Ksiazek; Ray R Arthur; Andre Ndikuyeze; Naphtali N Agata; Clarence J Peters
Journal:  Emerg Infect Dis       Date:  2002-02       Impact factor: 6.883

8.  Role of Culex and Anopheles mosquito species as potential vectors of rift valley fever virus in Sudan outbreak, 2007.

Authors:  Alaaeddeen M Seufi; Fatma H Galal
Journal:  BMC Infect Dis       Date:  2010-03-11       Impact factor: 3.090

9.  Rift Valley fever outbreak with East-Central African virus lineage in Mauritania, 2003.

Authors:  Ousmane Faye; Mawlouth Diallo; Djibril Diop; O Elmamy Bezeid; Hampathé Bâ; Mbayame Niang; Ibrahima Dia; Sid Ahmed Ould Mohamed; Kader Ndiaye; Diawo Diallo; Peinda Ogo Ly; Boubacar Diallo; Pierre Nabeth; François Simon; Baïdy Lô; Ousmane Madiagne Diop
Journal:  Emerg Infect Dis       Date:  2007-07       Impact factor: 6.883

10.  Amplification of the sylvatic cycle of dengue virus type 2, Senegal, 1999-2000: entomologic findings and epidemiologic considerations.

Authors:  Mawlouth Diallo; Yamar Ba; Amadou A Sall; Ousmane M Diop; Jacques A Ndione; Mireille Mondo; Lang Girault; Christian Mathiot
Journal:  Emerg Infect Dis       Date:  2003-03       Impact factor: 6.883

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.